Skip to main content

Table 1 Summary of clinical data from patients included in all groups

From: Changes in receptivity epithelial cell markers of endometrium after ovarian stimulation treatments: its role during implantation window

  OP UI CC-treated rFSH-treated
No. of patients (n) 12 10 12 10
Age (years) 30.83 ± 3.27 31.32 ± 3.58 31 ± 4.39 30.46 ± 3.95
Body mass index (kg/m2) 26.24 ± 2.70 26.48 ± 2.91 26.74 ± 2.80 25.98 ± 2.70
Basal hormonal profile     
PRL (ng/mL) 17.46 ± 2.44 13.78 ± 2.32 15.93 ± 2.82 12.75 ± 3.11
E2 (pg/mL) 35.13 ± 1.85 27.34 ± 3.12 46.61 ± 2.67 24.8 ± 2.28
LH (IU/L) 6.42 ± 1.16 4.98 ± 0.84 4.82 ± 1.07 5.80 ± 0.77
FSH (IU/L) 7.27 ± 0.94 8.86 ± 1.16 5.79 ± 0.79 6.07 ± 0.64
LH + 7 day hormonal profile     
E2 (pg/mL) 26 ± 2.04 31.05 ± 3.08 25.33 ± 2.16 48.51 ± 3.27
P4 (ng/mL) 12.01 ± 1.54 7.19 ± 1.98 20.87 ± 4.32 6.97 ± 1.14
Histological dating (cycle day) 19 ± 0.42 19 ± 0.7 19 ± 0.44 17 ± 0.79
  1. Clinical data from the ovulatory patients (OP), untreated infertile (UI), clomiphene citrate (CC) and recombinant follicle stimulating hormone (rFSH) treated patients. Data represents mean ± SE. Hormonal measurement at basal condition (day 3) and after treatments in LH + 7 day, as well as histological dating in all groups